Clinical Trials Directory

Trials / Completed

CompletedNCT02510482

Biological Variation of Cardiac Biomarkers in Aortic Valve Stenosis

Status
Completed
Phase
Study type
Observational
Enrollment
25 (actual)
Sponsor
Maastricht University Medical Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Calcified aortic valve stenosis (CAVS) is a progressive disease and nowadays, the cornerstone in diagnostics and follow-up is echocardiography. Cardiac biomarkers (such as cardiac troponins T and I and NT-pro-BNP) hold promise to fulfil a role in early recognition of complications concerning the aortic valve and decompensation. For this purpose, it is important to assess the normal biological variation (BV) of cardiac biomarkers in CAVS. The assessment of biological variation will contribute to a better understanding of fluctuation of cardiac biomarkers in subjects with stable CAVS. These data will improve monitoring of CAVS using cardiac biomarkers.

Conditions

Interventions

TypeNameDescription
OTHERNo intervention

Timeline

Start date
2015-08-01
Primary completion
2017-10-16
Completion
2017-10-16
First posted
2015-07-29
Last updated
2017-10-18

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT02510482. Inclusion in this directory is not an endorsement.